Cargando…
Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective
The incidence rate of breast cancers in People’s Republic of China has increased in the last decade, and many cases are responsive to hormone therapies. The third-generation aromatase inhibitor letrozole inhibits estrogen production, and is more efficacious than the estrogen receptor inhibitor tamox...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780194/ https://www.ncbi.nlm.nih.gov/pubmed/27042100 http://dx.doi.org/10.2147/OTT.S81087 |